Fog Pharmaceuticals Patents – Insights & Stats (Updated 2023)

Fog Pharmaceuticals has a total of 54 patents globally, out of which 1 has been granted. Of these 54 patents, more than 88% patents are active. Europe is where Fog Pharmaceuticals has filed the maximum number of patents, followed by United States of America and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Fog Pharmaceuticals.

Fog Pharmaceuticals was founded in the year 2015. The Company operates as a biotechnology company. The Company builds a drug discovery platform to develop cell-penetrating mini-proteins for the treatment of cancer.

Do read about some of the most popular patents of Fog Pharmaceuticals which have been covered by us in this article and also you can find Fog Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Fog Pharmaceuticals patent portfolio.

How many patents does the founder and the CEO of Fog Pharmaceuticals have?

The founder John McGee has 0 patent, Sir David Lane has 0 patent, Weiqing Zhou has 0 patent and CEO Greg Verdine has 0 patents.

How many patents does Fog Pharmaceuticals have?

Fog Pharmaceuticals has a total of 54 patents globally. These patents belong to 966 unique patent families. Out of 54 patents, 7 patents are active.

How Many Patents did Fog Pharmaceuticals File Every Year?

Fog Pharmaceuticals Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantFog Pharmaceuticals Applications FiledFog Pharmaceuticals Patents Granted
20232
20221
2021241
20208
20199
201810

How many Fog Pharmaceuticals patents are Alive/Dead?

Fog Pharmaceuticals Patent Portfolio

How Many Patents did Fog Pharmaceuticals File in Different Countries?

Fog Pharmaceuticals Worldwide Patent Filing

Countries in which Fog Pharmaceuticals Filed Patents

CountryPatents
Europe6
United States Of America5
Australia5
Canada5
China4
Singapore3
Mexico3
Korea (South)3
Brazil3
South Africa3
Israel3
India2
New Zealand1
Hong Kong (S.A.R.)1

Where are Research Centres of Fog Pharmaceuticals Patents Located?

The Research Centre for all the Fog Pharmaceuticals patents is the United States of America.

What Percentage of Fog Pharmaceuticals US Patent Applications were Granted?

Fog Pharmaceuticals (Excluding its subsidiaries) has filed 5 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100.0%.

Below are the key stats of Fog Pharmaceuticals patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Fog Pharmaceuticals?

Law FirmTotal ApplicationsSuccess Rate
Fogpharma 20126755100.00%

What are Fog Pharmaceuticals key innovation segments?

What Technologies are Covered by Fog Pharmaceuticals?

The chart below distributes patents filed by Fog Pharmaceuticals in different countries on the basis of the technology protected in patents. It also represents the markets where Fog Pharmaceuticals thinks it’s important to protect particular technology inventions.

R&D Focus: How has Fog Pharmaceuticals search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Fog Pharmaceuticals?

Related Articles

Celcem Patents – Insights & Stats (Updated 2024)

Celcem has a total of 28 patents globally, out of which all patents have been granted. Of these 28 patents, all patents patents are active. Singapore is where Celcem has filed the maximum number of patents. Parallelly, Singapore seems to be the main focused R&D centre and also is the

Read More »

Leave a Comment

Fill the form to get the details:

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.